Mai ka puka ʻana mai o ka maʻi maʻi COVID-19, nui ka poʻe i ʻike ʻole i nā ʻano ʻike like ʻole, me ka ʻike ʻana i ka waikawa nucleic, ka ʻike antibody, a me ka ʻike antigen.Hoʻohālikelike kēia ʻatikala i kēlā mau ʻano ʻike.
ʻO ka ʻike ʻana i ka waikawa nucleic i kēia manawa ʻo ka "standard gula" no ka ʻike ʻana i ka coronavirus novel a ʻo ia ke ʻano nui o ka hoʻāʻo ʻana ma Kina.Loaʻa i ka ʻike waika nucleic nā koi kiʻekiʻe no nā lako ʻike, ka hoʻomaʻemaʻe ʻana o ke keʻena hana a me nā mea hoʻohana, a he pipiʻi nā lako PCR kiʻekiʻe, a he lōʻihi ka manawa ʻike.No laila, ʻoiai he ala ia no ka hōʻoia ʻana, ʻaʻole pili ia no ka nānā wikiwiki ʻana i ka nui ma lalo o ke kūlana o ka nele o ka lako.
Ke hoʻohālikelike ʻia me ka ʻike ʻana i ka waikawa nucleic, ʻo nā ʻano ʻike wikiwiki o kēia manawa ka nui o ka ʻike antigen a me ka ʻike antibody.Nānā ka ʻike antigen inā he mau pathogens i loko o ke kino, aʻo ka ʻike antibody e nānā inā ua hoʻomohala ke kino i ke kūʻē i ka pathogen ma hope o ka maʻi.
I kēia manawa, ʻike pinepine ka ʻike antibody i nā antibodies IgM a me IgG i ka serum kanaka.Ma hope o ke komo ʻana o ka maʻi maʻi i ke kino o ke kanaka, he 5-7 mau lā no ka hana ʻana i nā antibodies IgM, a hana ʻia nā antibodies IgG i nā lā 10-15.No laila, ʻoi aku ka nui o ka loaʻa ʻana o ka ʻike ʻana me ka ʻike antibody, a ʻo ka mea maʻi i ʻike ʻia ua loaʻa i nā poʻe he nui.
Kiʻi 1:ʻO NEWGENE Huahana ʻIke Antibody
Ke hoʻohālikelike ʻia me ka ʻike antibody, hiki i ka ʻike antigen ke ʻike maʻamau i ka maʻi i loko o ka wā incubation, ka manawa koʻikoʻi a i ʻole ka wā mua o ka maʻi, a ʻaʻole koi i ka ʻenehana kikowaena a me nā hana ʻoihana.He kūpono loa ka ʻike antigen no nā hiʻohiʻona kahi i nele ai nā mea lapaʻau a me nā ʻoihana.He mea nui ia no ka ʻike mua ʻana a me ka mālama mua ʻana i nā maʻi me ka maʻi maʻi COVID-19.
Kiʻi 2:NEWGENE Huahana ʻIke Antigen
ʻO ka Novel Coronavirus Spike Protein Detection Kit i hoʻomohala ʻia a hana ʻia e NEWGENE ʻo ia kekahi o nā huahana ʻike antigen mua loa i kūkulu ʻia ma Kina.Ua hoʻopaʻa inoa ʻia e ka British Medicines and Healthcare Products Regulatory Agency (MHRA), i loaʻa i ka EU CE palapala hōʻoia, a ua hoʻokomo maikaʻi ʻia i loko o ka "papa inoa ʻae ʻae" o ke Kuhina Kālepa Kina.
ʻAʻole mālama wale ka huahana i nā pono o ka ʻike wikiwiki, ka hana maʻalahi, ke kumu kūʻai haʻahaʻa, a me ke kūpaʻa maikaʻi, akā hoʻomaikaʻi nui hoʻi i ka ʻike kikoʻī a me ka pololei.I ka manawa like, hiki i kēia ʻenehana ke ʻike i nā coronaviruses i hoʻopili ʻia e ka ACE2 receptor.ʻOiai inā loaʻa ka maʻi i nā mutations, hiki ke hoʻokomo koke ʻia ka pahu ʻike i ka noi me ke kali ʻole i ka hoʻomohala ʻana o nā antibodies hou, e hāʻawi ana i kahi kākoʻo ʻenehana koʻikoʻi no ka hana anti-epidemi e hiki mai ana.
Ka manawa kau: Apr-01-2021